Please provide your email address to receive an email when new articles are posted on . Within the baricitinib group, patients experienced a mean Vitiligo Area Scoring Index score change of 44.8% from ...
In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...
INTERVALE, N.H., Oct. 28, 2025 /PRNewswire/ -- Cytokind announces recently published results in the peer-reviewed Multiple Sclerosis and Related Disorders journal, demonstrating that narrowband UVB ...
Patients with psoriasis exhibited superior efficacy outcomes when treated with ultraviolet (UV)-based phototherapy plus other adjuvant therapies vs UV monotherapy, with similar safety profiles shown ...
A retrospective cohort study found no significant associations between phototherapy without psoralens and the risk of skin cancer. Patients undergoing phototherapy without psoralens are not at an ...
Intervale, New Hampshire--(Newsfile Corp. - June 26, 2025) - Cytokind, a medical device and drug discovery company, is featured in the June 2025 issue of Scientific American in Rowan Jacobsen's ...
A retrospective study investigated skin cancer risk in a large cohort of patients treated with ultraviolet light therapy between May 1977 and November 2018. Patients were treated with narrowband UVB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results